Simpson Thacher is representing Alpharma Inc. in connection with King Pharmaceuticals, Inc.’s unsolicited offer to acquire all outstanding shares of Alpharma for $37.00 per share. In addition, Simpson Thacher is representing Alpharma in the related shareholder litigation against Alpharma and its directors arising from the transaction.
Alpharma is an NYSE-listed global specialty pharmaceutical company based in Bridgewater, NJ.
The Simpson Thacher team representing Alpharma includes Bill Dougherty, Mario A. Ponce, Anthony D. King, Amie R. Siebert and Scott Reardon (M&A), Alvin Brown and Joseph Tobin (Employee Benefits), Steve Todrys and Sima Gandhi (Tax), and Michael J. Chepiga, Paul C. Gluckow, Jason S. Stone, Marsha W. Yee, Ihsan Dogramaci and Joshua Slocum (Litigation).